Steris (STE) Tops Q2 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $208.65 -1.15%
Revenue Growth %: +6.8%
Financial Fact:
Total operating expenses: 186.66M
Today's EPS Names:
TAYD, TMQ, OMH, More
Revenue Growth %: +6.8%
Financial Fact:
Total operating expenses: 186.66M
Today's EPS Names:
TAYD, TMQ, OMH, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q2 EPS of $1.99, $0.17 better than the analyst estimate of $1.82. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.15 billion.
GUIDANCE:
Steris sees FY2022 EPS of $7.60-$7.85, versus the consensus of $7.72.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- Clarivate completes $600M sale of life sciences unit to Altaris
- Taylor Devices (TAYD) Misses Q1 EPS by 79c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
